PISCATAWAY, N.J. — Camber Specialty, a division of Camber Pharmaceuticals, has launched Sugammadex Injection [soo-GAM-ma-dex], its first Day 1 injectable product.
“We are proud to achieve our first Day 1 launch with Sugammadex Injection,” said Tom DeStefano, Vice President of Specialty Sales. “This milestone reflects our commitment to expanding access to high-quality injectable products that support healthcare providers and their patients.”
Generic for Bridion®, Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients 2 years of age and older undergoing surgery.
Sugammadex Injection is available in:
- 200 mg/2 mL (100 mg/mL) | 10 Single-Dose 2 mL Vials
- 500 mg/5 mL (100 mg/mL) | 10 Single-Dose 5 mL Vials
To learn more about Sugammadex, click here.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
